You are currently on the new version of our website. Access the old version .

457 Results Found

  • Review
  • Open Access
24 Citations
11,043 Views
12 Pages

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer

  • Takuya Tsujino,
  • Kazumasa Komura,
  • Teruo Inamoto and
  • Haruhito Azuma

26 November 2021

Prostate cancer (PCa) is one of the common malignancies in male adults. Recent advances in omics technology, especially in next-generation sequencing, have increased the opportunity to identify genes that correlate with cancer diseases, including PCa...

  • Article
  • Open Access
2 Citations
3,327 Views
22 Pages

CRISPR Screen Identifies the RNA-Binding Protein Eef1a1 as a Key Regulator of Myogenesis

  • Weiwei Liu,
  • Wei Wang,
  • Zishuai Wang,
  • Xinhao Fan,
  • Wangchang Li,
  • Yuxin Huang,
  • Xiaogan Yang and
  • Zhonglin Tang

Skeletal muscle myogenesis hinges on gene regulation, meticulously orchestrated by molecular mechanisms. While the roles of transcription factors and non-coding RNAs in myogenesis are widely known, the contribution of RNA-binding proteins (RBPs) has...

  • Article
  • Open Access
4 Citations
4,505 Views
16 Pages

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

  • Chen Gao,
  • Xiaolan Qi,
  • Xin Gao,
  • Jin Li,
  • Yumin Qin,
  • Yunjun Yin,
  • Fei Gao,
  • Tao Feng,
  • Sen Wu and
  • Xuguang Du

25 July 2022

Pluripotency maintenance and exit in embryonic stem cells is a focal topic in stem cell biology. However, the effects of screening under very stringent culture conditions (e.g., differentiation medium, no leukemia inhibitory factor, no chemical inhib...

  • Article
  • Open Access
5 Citations
4,201 Views
13 Pages

CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication

  • Shwetha Shivaprasad,
  • Wenjie Qiao,
  • Kuo-Feng Weng,
  • Pavithra Umashankar,
  • Jan E. Carette and
  • Peter Sarnow

3 May 2024

The dengue virus is a single-stranded, positive-sense RNA virus that infects ~400 million people worldwide. Currently, there are no approved antivirals available. CRISPR-based screening methods have greatly accelerated the discovery of host factors t...

  • Abstract
  • Open Access
2 Citations
1,865 Views
1 Page

A Genome-Wide CRISPR Activation Screen Identifies Genes Involved in Protection from Zika Virus Infection

  • Anna Dukhovny,
  • Kevin Lamkiewicz,
  • Qian Chen,
  • Markus Fricke,
  • Nabila Jabrane-Ferrat,
  • Manja Marz,
  • Jae U. Jung and
  • Ella Hava Sklan

Zika virus (ZIKV) is an arthropod-borne emerging pathogen causing febrile illness. ZIKV is associated with the Guillain–Barré syndrome and other neurological complications. The vertical transmission of ZIKV can cause fetus demise, stillb...

  • Article
  • Open Access
3 Citations
2,650 Views
21 Pages

Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells

  • Louis-Alexandre Fournier,
  • Forouh Kalantari,
  • James P. Wells,
  • Joon Seon Lee,
  • Genny Trigo-Gonzalez,
  • Michelle M. Moksa,
  • Theodore Smith,
  • Justin White,
  • Alynn Shanks and
  • Peter C. Stirling
  • + 4 authors

24 August 2024

ARID1A is the core DNA-binding subunit of the BAF chromatin remodeling complex and is mutated in about 8% of all cancers. The frequency of ARID1A loss varies between cancer subtypes, with clear cell ovarian carcinoma (CCOC) presenting the highest inc...

  • Article
  • Open Access
4 Citations
8,074 Views
17 Pages

Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma

  • Risky Oktriani,
  • Anna Chiara Pirona,
  • Lili Kalmár,
  • Ariani S. Rahadian,
  • Beiping Miao,
  • Andrea S. Bauer,
  • Jörg D. Hoheisel,
  • Michael Boettcher and
  • Haoqi Du

31 October 2024

Background/Objectives: Early and aggressive metastasis is a major feature of pancreatic ductal adenocarcinoma. Understanding the processes underlying metastasis is crucial for making a difference to disease outcome. Towards these ends, we looked in a...

  • Article
  • Open Access
6 Citations
3,559 Views
23 Pages

31 August 2023

We sought to explore the hypothesis that host factors required for HIV-1 replication also play a role in latency reversal. Using a CRISPR gene library of putative HIV dependency factors, we performed a screen to identify genes required for latency re...

  • Review
  • Open Access
25 Citations
9,357 Views
22 Pages

CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer

  • Laia Castells-Roca,
  • Eudald Tejero,
  • Benjamín Rodríguez-Santiago and
  • Jordi Surrallés

30 March 2021

Cancer is a complex disease resulting from the accumulation of genetic dysfunctions. Tumor heterogeneity causes the molecular variety that divergently controls responses to chemotherapy, leading to the recurrent problem of cancer reappearance. For ma...

  • Review
  • Open Access
6 Citations
4,722 Views
16 Pages

Glioblastoma (GBM) is the most common malignant brain tumor in adults. Despite advancements in treatment, the prognosis for patients with GBM remains poor due to its aggressive nature and resistance to therapy. CRISPR-based genetic screening has emer...

  • Review
  • Open Access
2 Citations
2,931 Views
19 Pages

CRISPR/Cas-Based Prenatal Screening for Aneuploidy: Challenges and Opportunities for Early Diagnosis

  • Irisappan Ganesh,
  • Ilangovan Karthiga,
  • Manoranjani Murugan,
  • Kumar Rangarajalu,
  • Vishnu Bhat Ballambattu and
  • Sambandam Ravikumar

27 March 2025

Aneuploidy is increasingly recognized globally as a common cause of miscarriage among expectant mothers. The existing prenatal screening techniques for detecting aneuploidy have several limitations. The ability to diagnose aneuploidy early in a non-i...

  • Review
  • Open Access
14 Citations
5,921 Views
15 Pages

To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases

  • Iichiroh Onishi,
  • Kouhei Yamamoto,
  • Yuko Kinowaki,
  • Masanobu Kitagawa and
  • Morito Kurata

15 November 2021

CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic...

  • Review
  • Open Access
7 Citations
5,364 Views
16 Pages

Flavivirus–Host Interaction Landscape Visualized through Genome-Wide CRISPR Screens

  • Aditi Kanojia,
  • Mansi Sharma,
  • Rishad Shiraz and
  • Shashank Tripathi

30 September 2022

Flaviviruses comprise several important human pathogens which cause significant morbidity and mortality worldwide. Like any other virus, they are obligate intracellular parasites. Therefore, studying the host cellular factors that promote or restrict...

  • Article
  • Open Access
1,417 Views
14 Pages

High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System

  • Jiasong Chang,
  • Xiulong Yang,
  • Tong Zhang,
  • Hao Sun,
  • Hongying Cheng,
  • Zhangrong Jia,
  • Yiying Li,
  • Sanyuan Ma,
  • Teng Sun and
  • Jimin Cao

17 April 2025

Genome editing is a promising therapeutic strategy for genetic disorders by modifying the genome precisely, especially the CRISPR/Cas9 system. However, a major limitation of CRISPR/Cas9 in gene therapy is the biosafety issues caused by off-target eff...

  • Article
  • Open Access
6 Citations
2,929 Views
13 Pages

Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings

  • Yosuke Tanaka,
  • Hidetaka Kambayashi,
  • Akiko Yamamoto,
  • Iichiroh Onishi,
  • Keisuke Sugita,
  • Miwa Matsumura,
  • Sachiko Ishibashi,
  • Masumi Ikeda,
  • Kouhei Yamamoto and
  • Morito Kurata

MYC is a major oncogene that plays an important role in cell proliferation in human cancers. Therefore, the mechanism behind MYC regulation is a viable therapeutic target for the treatment of cancer. Comprehensive and efficient screening of MYC regul...

  • Protocol
  • Open Access
10 Citations
4,935 Views
14 Pages

An Efficient Workflow for Screening and Stabilizing CRISPR/Cas9-Mediated Mutant Lines in Bombyx mori

  • Daniel Brady,
  • Alessio Saviane,
  • Silvia Cappellozza and
  • Federica Sandrelli

29 December 2020

The domestic silkworm Bombyx mori is extensively studied as a model organism for lepidopteran genetics and has an economic value in silk production. Silkworms also have applications in biomedical and cosmetic industries, and the production of mutant...

  • Article
  • Open Access
17 Citations
5,723 Views
15 Pages

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer

  • Hai Yang,
  • Bin Liu,
  • Dongxue Liu,
  • Zhirong Yang,
  • Shuman Zhang,
  • Pengyan Xu,
  • Yuming Xing,
  • Isabella Kutschick,
  • Susanne Pfeffer and
  • Christian Pilarsky
  • + 1 author

27 June 2022

Pancreatic cancer is one of the most lethal cancers. Due to the difficulty of early diagnosis, most patients are diagnosed with metastasis or advanced-stage cancer, limiting the possibility of surgical treatment. Therefore, chemotherapy is applied to...

  • Article
  • Open Access
6 Citations
6,897 Views
16 Pages

Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening

  • Kinga Vojnits,
  • Mio Nakanishi,
  • Deanna Porras,
  • Yeonjoon Kim,
  • Zhuohang Feng,
  • Diana Golubeva and
  • Mick Bhatia

Application of the CRISPR/Cas9 system to knock in fluorescent proteins to endogenous genes of interest in human pluripotent stem cells (hPSCs) has the potential to facilitate hPSC-based disease modeling, drug screening, and optimization of transplant...

  • Review
  • Open Access
653 Views
15 Pages

Head-and-neck squamous cell carcinoma (HNSCC) remains a lethal malignancy with stagnant survival despite advances in surgery, radiotherapy, and systemic therapy. Beyond cetuximab and PD-1 inhibitors, there are only a few targeted options, which benef...

  • Review
  • Open Access
45 Citations
12,069 Views
14 Pages

The cellular signalling process is a highly complex mechanism, involving multiple players, which together orchestrate the cell’s response to environmental changes and perturbations. Given the multitude of genes that participate in the process of cell...

  • Article
  • Open Access
23 Citations
10,576 Views
16 Pages

Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease

  • Hui-Yung Song,
  • Huai-Chih Chiang,
  • Wei-Lien Tseng,
  • Ping Wu,
  • Chian-Shiu Chien,
  • Hsin-Bang Leu,
  • Yi-Ping Yang,
  • Mong-Lien Wang,
  • Yuh-Jyh Jong and
  • Shih-Hwa Chiou
  • + 1 author

13 December 2016

The CRISPR/Cas9 Genome-editing system has revealed promising potential for generating gene mutation, deletion, and correction in human cells. Application of this powerful tool in Fabry disease (FD), however, still needs to be explored. Enzyme replace...

  • Article
  • Open Access
961 Views
32 Pages

CRISPR-Cas9 Genome and Double-Knockout Screening to Identify Novel Therapeutic Targets for Chemoresistance in Triple-Negative Breast Cancer

  • Shuai Shao,
  • Shangjia Li,
  • Yang Huo,
  • Shan Tang,
  • Birkan Gökbağ,
  • Kunjie Fan,
  • Yirui Huang,
  • Lingling Wang,
  • Gregory Nagy and
  • Lang Li
  • + 2 authors

3 December 2025

Background/Objectives: Triple-negative breast cancer (TNBC) accounts for 15 to 20% of breast cancer cases and contributes to a disproportionate 35% of breast cancer deaths. Its resistance to chemotherapy presents a significant challenge. Methods: We...

  • Article
  • Open Access
20 Citations
4,316 Views
17 Pages

Genome-Scale CRISPR Knockout Screening Identifies BACH1 as a Key Regulator of Aflatoxin B1-Induced Oxidative Damage

  • Jinfu Zhang,
  • Siyi Hu,
  • Changzhi Zhao,
  • Yuan Zhou,
  • Lu Zhang,
  • Hailong Liu,
  • Peng Zhou,
  • Sheng Li,
  • Liangliang Fu and
  • Shengsong Xie
  • + 8 authors

10 September 2022

Aflatoxin B1 (AFB1) is amongst the mycotoxins commonly affecting human and animal health, raising global food safety and control concerns. The mechanisms underlying AFB1 toxicity are poorly understood. Moreover, antidotes against AFB1 are lacking. Ge...

  • Article
  • Open Access
14 Citations
5,896 Views
16 Pages

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer

  • Bin Lan,
  • Siyuan Zeng,
  • Shuman Zhang,
  • Xiaofan Ren,
  • Yuming Xing,
  • Isabella Kutschick,
  • Susanne Pfeffer,
  • Benjamin Frey,
  • Nathalie Britzen-Laurent and
  • Christian Pilarsky
  • + 1 author

10 January 2022

Although radiation therapy has recently made great advances in cancer treatment, the majority of patients diagnosed with pancreatic cancer (PC) cannot achieve satisfactory outcomes due to intrinsic and acquired radioresistance. Identifying the molecu...

  • Article
  • Open Access
3 Citations
3,220 Views
18 Pages

Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen

  • Kseniya Glinkina,
  • Arwin Groenewoud,
  • Amina F. A. S. Teunisse,
  • B. Ewa Snaar-Jagalska and
  • Aart G. Jochemsen

29 June 2022

Currently, no systemic treatment is approved as the standard of care for metastatic uveal melanoma (UM). mTOR has been evaluated as a drug target in UM. However, one of the main limitations is dose reduction due to adverse effects. The combination of...

  • Brief Report
  • Open Access
6 Citations
2,655 Views
11 Pages

CRISPR-Cas9-Mediated Cytosine Base Editing Screen for the Functional Assessment of CALR Intron Variants in Japanese Encephalitis Virus Replication

  • Youcai Xiong,
  • Xiaoning Xi,
  • Yue Xiang,
  • Sheng Li,
  • Hailong Liu,
  • Yinyu Su,
  • Ruigao He,
  • Chong Xiong,
  • Bingrong Xu and
  • Jinxue Ruan
  • + 5 authors

28 August 2023

The Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes viral encephalitis in humans, pigs and other mammals across Asia and the Western Pacific. Genetic screening tools such as CRISPR screening, DNA sequencing and RNA interf...

  • Article
  • Open Access
1,722 Views
20 Pages

Genome-Wide CRISPR-Cas9 Knockout Screening Identifies NUDCD2 Depletion as Sensitizer for Bortezomib, Carfilzomib and Ixazomib in Multiple Myeloma

  • Sophie Vlayen,
  • Tim Dierckx,
  • Marino Caruso,
  • Swell Sieben,
  • Kim De Keersmaecker,
  • Dirk Daelemans and
  • Michel Delforge

16 July 2025

Background/Objectives: The treatment of multiple myeloma (MM) remains a challenge, as almost all patients will eventually relapse. Proteasome inhibitors are a cornerstone in the management of MM. Unfortunately, validated biomarkers predicting drug re...

  • Review
  • Open Access
31 Citations
15,447 Views
22 Pages

CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions

  • Makda Gebre,
  • Jason L. Nomburg and
  • Benjamin E. Gewurz

30 January 2018

Clustered regularly interspaced short palindromic repeats (CRISPR) has greatly expanded the ability to genetically probe virus–host interactions. CRISPR systems enable focused or systematic, genomewide studies of nearly all aspects of a virus lifecyc...

  • Communication
  • Open Access
2 Citations
2,756 Views
13 Pages

A CRISPR Screen Identifies the E3 Ubiquitin Ligase Rfwd2 as a Negative Regulator of Glucose Uptake in Brown Adipocytes

  • Matthew D. Lynes,
  • Qian Huang,
  • Carolina Cora,
  • Sheng-Chiang Su,
  • Peng Yi and
  • Yu-Hua Tseng

26 September 2023

Brown adipose tissue activation increases energy expenditure and has been shown to improve glucose tolerance, making it a promising target for the treatment of obesity and type 2 diabetes. Brown adipocytes differentiate into cells with multilocular l...

  • Article
  • Open Access
27 Citations
5,726 Views
17 Pages

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma

  • Shigeki Suemura,
  • Takahiro Kodama,
  • Yuta Myojin,
  • Ryoko Yamada,
  • Minoru Shigekawa,
  • Hayato Hikita,
  • Ryotaro Sakamori,
  • Tomohide Tatsumi and
  • Tetsuo Takehara

13 September 2019

Regorafenib is used for hepatocellular carcinoma (HCC), but its response does not last long, partly due to chemoresistance acquisition. We performed a clustered regularly interspaced short palindromic repeats (CRISPR)-based loss-of-function genetic s...

  • Article
  • Open Access
5 Citations
3,729 Views
13 Pages

Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway

  • Jeong-Min Park,
  • Huimin Zhang,
  • Litong Nie,
  • Chao Wang,
  • Min Huang,
  • Xu Feng,
  • Mengfan Tang,
  • Zhen Chen,
  • Yun Xiong and
  • Junjie Chen
  • + 3 authors

Etoposide (ETO) is an anticancer drug that targets topoisomerase II (TOP2). It stabilizes a normally transient TOP2–DNA covalent complex (TOP2cc), thus leading to DNA double-strand breaks (DSBs). Tyrosyl-DNA phosphodiesterases two (TDP2) is dir...

  • Review
  • Open Access
9 Citations
5,107 Views
21 Pages

The Current Situation and Development Prospect of Whole-Genome Screening

  • Caiting Yang,
  • Yu Lei,
  • Tinglin Ren and
  • Mingze Yao

High-throughput genetic screening is useful for discovering critical genes or gene sequences that trigger specific cell functions and/or phenotypes. Loss-of-function genetic screening is mainly achieved through RNA interference (RNAi), CRISPR knock-o...

  • Review
  • Open Access
8 Citations
4,813 Views
12 Pages

13 October 2022

Clustered regularly interspaced short palindromic repeats (CRISPR) are widely used in cancer research to edit specific genes and study their functions. This applies both to in vitro and in vivo studies where CRISPR technology has accelerated the gene...

  • Review
  • Open Access
14 Citations
4,451 Views
24 Pages

Functional Screening Techniques to Identify Long Non-Coding RNAs as Therapeutic Targets in Cancer

  • Kathleen M. Lucere,
  • Megan M. R. O’Malley and
  • Sarah D. Diermeier

9 December 2020

Recent technological advancements such as CRISPR/Cas-based systems enable multiplexed, high-throughput screening for new therapeutic targets in cancer. While numerous functional screens have been performed on protein-coding genes to date, long non-co...

  • Article
  • Open Access
3 Citations
4,505 Views
22 Pages

Validation of Candidate Host Cell Entry Factors for Bovine Herpes Virus Type-1 Based on a Genome-Wide CRISPR Knockout Screen

  • Wenfang Spring Tan,
  • Enguang Rong,
  • Inga Dry,
  • Simon Lillico,
  • Andy Law,
  • Paul Digard,
  • Bruce Whitelaw and
  • Robert G. Dalziel

15 February 2024

To identify host factors that affect Bovine Herpes Virus Type 1 (BoHV-1) infection we previously applied a genome wide CRISPR knockout screen targeting all bovine protein coding genes. By doing so we compiled a list of both pro-viral and anti-viral p...

  • Review
  • Open Access
24 Citations
11,290 Views
20 Pages

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

  • Shuai Ding,
  • Jinfeng Liu,
  • Xin Han and
  • Mengfan Tang

15 November 2023

The Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system, an RNA-based adaptive immune system found in bacteria and archaea, has catalyzed the development and application of a new generation of ge...

  • Review
  • Open Access
9 Citations
6,189 Views
27 Pages

Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation

  • William J. Cisneros,
  • Daphne Cornish and
  • Judd F. Hultquist

Human Immunodeficiency Virus (HIV) interacts with a wide array of host factors at each stage of its lifecycle to facilitate replication and circumvent the immune response. Identification and characterization of these host factors is critical for eluc...

  • Review
  • Open Access
7 Citations
5,911 Views
17 Pages

28 September 2021

The presence of latently infected cells and reservoirs in HIV-1 infected patients constitutes a significant obstacle to achieve a definitive cure. Despite the efforts dedicated to solve these issues, the mechanisms underlying viral latency are still...

  • Review
  • Open Access
14 Citations
9,810 Views
14 Pages

Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing

  • Jia-Xin Tang,
  • Angela Pyle,
  • Robert W. Taylor and
  • Monika Oláhová

12 October 2021

Mitochondrial disease originates from genetic changes that impact human bodily functions by disrupting the mitochondrial oxidative phosphorylation system. MitoCarta is a curated and published inventory that sheds light on the mitochondrial proteome,...

  • Review
  • Open Access
8 Citations
6,104 Views
20 Pages

12 August 2020

The development of high-throughput gene manipulating tools such as short hairpin RNA (shRNA) and CRISPR/Cas9 libraries has enabled robust characterization of novel functional genes contributing to the pathological states of the diseases. In acute mye...

  • Article
  • Open Access
3,672 Views
12 Pages

Identification of NRAS Downstream Genes with CRISPR Activation Screening

  • Akiya Tatsumi,
  • Haruka Hirakochi,
  • Satomi Inoue,
  • Yosuke Tanaka,
  • Hidehiro Furuno,
  • Masumi Ikeda,
  • Sachiko Ishibashi,
  • Towako Taguchi,
  • Kouhei Yamamoto and
  • Morito Kurata
  • + 3 authors

23 October 2022

Mutations in NRAS constitutively activate cell proliferation signaling in malignant neoplasms, such as leukemia and melanoma, and the clarification of comprehensive downstream genes of NRAS might lead to the control of cell-proliferative signals of N...

  • Review
  • Open Access
21 Citations
9,804 Views
37 Pages

Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow

  • Ekaterina S. Potekhina,
  • Dina Y. Bass,
  • Ilya V. Kelmanson,
  • Elena S. Fetisova,
  • Alexander V. Ivanenko,
  • Vsevolod V. Belousov and
  • Dmitry S. Bilan

25 December 2020

Genetically-encoded fluorescent sensors have been actively developed over the last few decades and used in live imaging and drug screening. Real-time monitoring of drug action in a specific cellular compartment, organ, or tissue type; the ability to...

  • Article
  • Open Access
18 Citations
5,765 Views
20 Pages

A Genome-Wide CRISPR/Cas9 Screen Reveals the Requirement of Host Sphingomyelin Synthase 1 for Infection with Pseudorabies Virus Mutant gDPass

  • Julia E. Hölper,
  • Finn Grey,
  • John Kenneth Baillie,
  • Tim Regan,
  • Nicholas J. Parkinson,
  • Dirk Höper,
  • Thiprampai Thamamongood,
  • Martin Schwemmle,
  • Katrin Pannhorst and
  • Barbara G. Klupp
  • + 1 author

9 August 2021

Herpesviruses are large DNA viruses, which encode up to 300 different proteins including enzymes enabling efficient replication. Nevertheless, they depend on a multitude of host cell proteins for successful propagation. To uncover cellular host facto...

  • Technical Note
  • Open Access
9 Citations
4,971 Views
11 Pages

Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic Deletions

  • Joseph Blayney,
  • Evangeline M. Foster,
  • Marta Jagielowicz,
  • Mira Kreuzer,
  • Matteo Morotti,
  • Katharina Reglinski,
  • Julie Huiyuan Xiao and
  • Philip Hublitz

Use of dual sgRNAs is a common CRISPR/Cas9-based strategy for the creation of genetic deletions. The ease of screening combined with a rather high rate of success makes this approach a reliable genome engineering procedure. Recently, a number of stud...

  • Communication
  • Open Access
2 Citations
4,272 Views
14 Pages

Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon

  • Guillem Pons,
  • Gabriel Gallo-Oller,
  • Natalia Navarro,
  • Patricia Zarzosa,
  • Júlia Sansa-Girona,
  • Lia García-Gilabert,
  • Ainara Magdaleno,
  • Miguel F. Segura,
  • Josep Sánchez de Toledo and
  • Josep Roma
  • + 1 author

7 March 2023

The identification of novel therapeutic targets for specific cancer molecular subtypes is crucial for the development of precision oncology. In the last few years, CRISPR/Cas9 screens have accelerated the discovery and validation of new targets assoc...

  • Review
  • Open Access
10 Citations
6,096 Views
15 Pages

Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology

  • Joffrey Mianné,
  • Chloé Bourguignon,
  • Chloé Nguyen Van,
  • Mathieu Fieldès,
  • Amel Nasri,
  • Said Assou and
  • John De Vos

25 May 2020

Recent advances in genome engineering based on the CRISPR/Cas9 technology have revolutionized our ability to manipulate genomic DNA. Its use in human pluripotent stem cells (hPSCs) has allowed a wide range of mutant cell lines to be obtained at an un...

  • Article
  • Open Access
7 Citations
4,020 Views
18 Pages

Identification of SYS1 as a Host Factor Required for Shiga Toxin-Mediated Cytotoxicity in Vero Cells

  • Chisato Sakuma,
  • Tsuyoshi Sekizuka,
  • Makoto Kuroda,
  • Kentaro Hanada and
  • Toshiyuki Yamaji

Shiga toxin (STx) or Vero toxin is a virulence factor produced by enterohemorrhagic Escherichia coli. The toxin binds to the glycosphingolipid globotriaosylceramide (Gb3) for its entry, and causes cell death by inhibiting ribosome function. Previousl...

  • Review
  • Open Access
15 Citations
10,683 Views
18 Pages

CRISPR Screening: Molecular Tools for Studying Virus–Host Interactions

  • Vladimir Chulanov,
  • Anastasiya Kostyusheva,
  • Sergey Brezgin,
  • Natalia Ponomareva,
  • Vladimir Gegechkori,
  • Elena Volchkova,
  • Nikolay Pimenov and
  • Dmitry Kostyushev

11 November 2021

CRISPR/Cas is a powerful tool for studying the role of genes in viral infections. The invention of CRISPR screening technologies has made it possible to untangle complex interactions between the host and viral agents. Moreover, whole-genome and pathw...

  • Review
  • Open Access
13 Citations
9,051 Views
34 Pages

High-Throughput CRISPR Screening in Hematological Neoplasms

  • Raquel Ancos-Pintado,
  • Irene Bragado-García,
  • María Luz Morales,
  • Roberto García-Vicente,
  • Andrés Arroyo-Barea,
  • Alba Rodríguez-García,
  • Joaquín Martínez-López,
  • María Linares and
  • María Hernández-Sánchez

25 July 2022

CRISPR is becoming an indispensable tool in biological research, revolutionizing diverse fields of medical research and biotechnology. In the last few years, several CRISPR-based genome-targeting tools have been translated for the study of hematologi...

  • Article
  • Open Access
2,777 Views
20 Pages

Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9

  • Jicheng Yang,
  • Fusheng Guo,
  • Hui San Chin,
  • Gao Bin Chen,
  • Ziyan Zhang,
  • Lewis Williams,
  • Andrew J. Kueh,
  • Pierce K. H. Chow,
  • Marco J. Herold and
  • Nai Yang Fu

29 July 2025

Conventional methods for generating knock-out or knock-in mammalian cell models using CRISPR-Cas9 genome editing often require tedious single-cell clone selection and expansion. In this study, we develop and optimise rapid and robust strategies to en...

of 10